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BACKGROUND: ALDH1A1 and ALDH1A3, the most renowned isozymes of aldehyde dehydrogenase (ALDH)1, are important in 
regulating the pluripotency of human mesenchymal stem 
cells (MSCs) and cancer stem cells (CSCs). The study 
aimed to analyze the mRNA expression of ALDH1A1 and 
ALDH1A3 genes in adipose stem cells (ASCs) and umbilical 
cord stem cells (UCSCs) along with their correlations to 
Oct-4 mRNA expression. Additionally, the interaction 
between these proteins was also investigated using in silico 
study to confirm the pluripotency of both MSCs compared 
to human breast ALDH+ CSCs.
METHODS: This research focused on determining mRNA 
levels of ALDH1A1, ALDH1A3 and Oct-4 in ASCs and 
UCSCs using one-step qRT-PCR. The data were then 
normalized to those in human breast CSCs and 18S rRNA. 
Oct-4 gene expression was also analyzed to determine the 
pluripotency of ASCs and UCSCs. The protein-protein 
interactions were in silico analyzed using String 9.1 
software. 
RESULTS: Relatively, ALDH1A3 was expressed at similar 
level in ASCs and UCSCs, while ALDH1A1 expression 
level was significantly higher in ASCs compared to UCSCs. 
In contrast to ALDH1A3, the expressions of ALDH1A1 
in both MSCs were significantly lower than breast CSCs 
similar to Oct-4 expressions, as also revealed by the in silico 
data showing the interaction between these proteins. This 
suggests the role of ALDH1A1 on pluripotency.
CONCLUSION: ALDH1A1 and ALDH1A3 were distinctly 
expressed in UCSCs and ASCs, which might be associated 
with unique properties of ASCs and UCSCs. This study 
may contribute to further research in terms of implication 
of ALDH1A1 and ALDH1A3 expressions towards the 
properties of MSCs and its application in stem cell therapy. 
KEywORDS:  ALDH1A1, ALDH1A3, UCSC, ASC, breast 
ALDH+ CSC, Oct-4
Indones Biomed J. 2018; 10(3): 290-6
Abstract
Introduction
Human aldehyde dehydrogenase (ALDH), a superfamily 
consisting of 19 isoforms, plays important role in 
irreversible oxidation of acetaldehyde.(1,2) ALDH1A1 
and ALDH1A3 belong to ALDH1A subfamily which have 
been suggested to play important role in retinoic signaling 
pathway.(1,3) Acting as a detoxification enzyme, both 
ALDH1A1 and ALDH1A3 catalyze the oxidation of retinal 
to retinoic acid, contributing to the characteristic of self-
protection in stem cells.(1,4) Moreover, they also influence 
the  stemness  regulation  in  terms of  cell  proliferation  and 
differentiation.(3,4)
 Mesenchymal stem cells (MSCs) can be abundantly 
obtained from human adult tissues (5-7) and share common 
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characteristics which include being plastic-adherent when 
maintained in standard culture condition, have multipotent 
capacity to differentiate into osteoblasts, adipocytes, 
and chondroblasts in vitro, while still express cluster of 
differentiation  (CD)73, CD90, and CD105, with lack of 
CD14, CD19, CD45, CD34 and human leukocyte antigen- 
DR isotype (HLA-DR) expression.(8) Recently, MSCs have 
been widely used in regenerative medicine. Among various 
kinds of MSCs, there are adipose-derived stem cells (ASCs) 
and umbilical cord stem cells (UCSCs) which are recently 
reported as preferable options for stem cell therapy.(6,9,10) 
This fact is due to their advantages over bone marrow-
derived stem cells such as being able to be obtained non-
invasively with minimal immunological and ethical issues.
(6,11)
  UCSCs are stem cells which can be obtained from 
total umbilical cord or various sections of umbilical cord, 
comprising Wharton’s jelly, and subendothelial layer of both 
umbilical arteries and umbilical vein excluding its inner 
blood vessel walls.(9,12) On the other hand, ASCs are stem 
cells which are retrieved from adipose tissue.(7,13) Aside 
from having the common characteristics of MSCs, UCSCs 
and ASCs can be differentiated in terms of proliferation 
ability and differentiation capability. It has been reported 
that UCSCs have higher proliferation ability compared to 
ASCs, while ASCs are more adipogenic than UCSCs.(14)
  Cancer stem cells (CSCs) have been reported to 
be responsible for initiation and maintenance of cancer 
due to their self-renewal, pluripotency, and tumorigenic 
properties, similar to normal stem cells.(15) Regarding 
the fact that ALDH1A1 and ALDH1A3 are found in both 
normal and cancer stem cells, the specific role of these 
genes in the aspect of stemness, especially pluripotency, 
remains unclear. Therefore, this study aimed to analyze the 
expression of ALDH1A1 and ALDH1A3 genes in ASCs and 
UCSCs relatively to human breast ALDH+ CSCs; along with 
the confirmation of its pluripotency when being compared 
to Oct-4 relative expression in both stem cells.
Methods
Stem Cell Specimens
This study has been approved by Health Research Ethics 
Committee of Faculty of Medicine Universitas Indonesia 
– Dr. Cipto Mangkunkusumo Hospital (No. 205/UN2.F1/
ETIK/2016). After informed consent, three specimens of 
ASCs were obtained from healthy women of reproductive 
age who underwent cosmetic liposuction, after informed 
consent,  at  HayandraLab,  while  three  UCSC  specimens 
were obtained from human placenta of women who 
underwent normal delivery. After being characterized and 
tested for its differentiation at HayandraLab and Stem 
Cell Medical Technology Integrated Service Unit (FKUI-
RSCM), ASCs and UCSCs were cultured in Alpha-MEM 
medium supplemented with 10% fetal bovine serum, 1% 
Penicillin-Streptomycin, 1% Gentamycin, 1% Fungizone, 
and 1% Glutamine under standard conditions (37°C, 20% 
O2, 5% CO2). Meanwhile, three samples of primary human 
breast CSCs (ALDH+) were obtained from Cancer Stem Cell 
Laboratory, Department of  Biochemistry and Molecular 
Biology, Faculty of Medicine, Universitas Indonesia. 
These samples were sorted using ALDEFLUOR™ Assay 
(STEMCELL Technologies, Vancouver, Canada) to obtain 
ALDH+ breast CSCs. Breast CSCs were cultured in serum-
free DMEM/F12 medium supplemented with 1% Penicillin-
Streptomycin, 1% Gentamycin and 1% Fungizone, under 
standard conditions, as described previously.(16)
Primer Design
Primers for ALDH1A1, ALDH1A3 and Oct-4 were obtained 
from previous study done by Purnamawati, et al.(17) The 
primers are listed in Table 1.
 
RNA Isolation and One-step Quantitative Real-time 
Polymerase Chain Reactionq (RT-PCR)
Total RNA samples were extracted with Tripure Isolation 
Reagent® (Roche, Mannheim, Germany) according to 
manufacturer’s instructions. Total RNA concentration was 
then quantified by spectrophotometry at λ 260 nm. One-step 
qRT-PCR was performed using KAPA SYBR® FAST One-
Step qRT-PCR Kit (Kapa Biosystems, Wilmington, United 
States of America) in the Exicycler™ 96 (Bioneer, Daejeon, 
Republic of Korea). A total of 200 ng RNA was diluted in 
nuclease free water, added to a reaction mixture containing 
10 µL of Master Mix, 0.4 µL of 10 µM forward primer, 0.4 
µL of 10 µM reverse primer and 0.4 µL of 50X RT Mix, and 
adjusted to 20 µL of solution.
 The qRT-PCR is done in triplicate in the following 
sequence: cDNA synthesis for 5 minutes at 42°C, 
inactivation of reverse transcriptase for 5 minutes at 95°C, 
40 cycles consisting of denaturation of double stranded 
DNA for 30 seconds at 95°C and gene annealing for 20 
seconds at different optimized temperatures for each genes 
(Table 1), and elongation for 20 seconds at 72°C.
  The measured gene expression was recorded in Cq, 
and the values were then normalized to the respective gene 
expression in ALDH+ breast CSCs and 18S rRNA gene as 
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Gene Forward Primer Reverse Primer
Amplicons 
(bp)
Annealing 
Temperature 
(°C)
ALDH1A1 (16) 5’-TTGGAAGATAGGGCCTGCAC-3’ 5’-GGAGGAAACCCTGCCTCTTTT-3’ 117 60
ALDH1A3 (16) 5’-CGACCTGGAGGGCTGTATTA-3’ 5’-TGGTGAAGCACACGACGTT-3’ 104 55
Oct-4 (16) 5’-GAGGAGTCCCAGGACATCAAA-3’ 5’-AGCTTCCTCCACCCACTTCT-3' 234 57
18S  (11) 5’-AAACGGCTACCACATCCAAG-3’ 5’-CCTCCAATGGATCCTCHTTA-3’ 155 59
Table 1. Primers, amplicons and annealing temperature of ALDH1A1, ALDH1A3, Oct-4 and 18S genes. 
bp: base pairs.
reference. Furthermore, melting curve analysis was also 
performed for each sample to evaluate the authenticity of 
the products.
 
Electrophoresis
To verify the PCR products, 2% agarose gel electrophoresis 
was performed and visualized using GelRed stain (Biotium, 
Hayward, California, USA).
 
Bioinformatic Analysis
To further explore the gene expression data, we conducted 
in silico protein-protein interaction analysis using the 
Search Tool for the Retrieval of Interacting Genes (STRING 
9.1) database. This software associates high throughput 
experiment  data  from  database  mining  and  literature, 
as  well  as  from  predictions  based  on  genomic  context 
analysis.
 
Statistical Analysis
Data are shown in relative expression±standard error. 
Statistical differences between two groups were analyzed 
using SPSS Software Version 20.0.0.0 by Independent 
T-Test, considering the p-value<0.05 is statistically 
significant.
Results
ALDH1A1 mRNA Expression Level in ASCs and UCSCs
To investigate the expression of ALDH1A1, qRT-PCR was 
conducted in ASCs and UCSCs. Single-peak melting curve 
was obtained from this PCR, suggesting that the amplified 
gene is indeed the gene of interest (ALDH1A1). Figure 1 
depicts that ALDH1A1 gene was expressed significantly 
higher in ASCs than UCSCs when being normalized to 
breast CSCs (p=0.01). Furthermore, this result also points 
out the lower expression of ALDH1A1 in MSCs (ASCs and 
UCSCs) compared to ALDH+ breast CSCs.
ALDH1A3 mRNA Expression Level in ASCs and UCSCs
Similar to ALDH1A1, ALDH1A3 gene expression was 
measured by conducting qRT-PCR in both ASCs and 
UCSCs samples. The quality of ALDH1A3 RT-PCR 
was measured using  its  single-peak  melting  curve. In 
the study, it was found that ALDH1A3 was expressed at 
similar level in ASCs and UCSCs (p=0.275), as depicted in 
Figure 2. Additionally, in contrast to ALDH1A1, ALDH1A3 
expression in both MSCs was higher than those expressed 
in ALDH+ breast CSCs.
Oct-4 mRNA Expression Level in ASCs and UCSCs
To explore whether there were any differences between 
ASCs and UCSCs in the aspect of pluripotency, Oct-4 
expression was also measured by RT-PCR. The melting 
curve analysis of Oct-4 RT-PCR results points out a single 
peak, suggesting that the amplified gene si indeed Oct-4. 
Figure 3 shows that there was no significant difference 
between ASCs and UCSCs in terms of Oct-4 expression 
(p=0.827). Moreover, Oct-4 is expressed significantly lower 
in MSCs compared to CSCs, in line with the expression of 
ALDH1A1.
ALDH1A1, ALDH1A3 and Oct-4 Protein-Protein 
Interactions
The  result  of  the  in  silico  analysis,  as  depicted  in 
Figure 4, indicates that there is a potential  protein-
protein  interaction between ALDH1A1 and pluripotency 
markers (POU class 5 homeobox 1 (POU5F1) (Oct-4), sex 
determining region Y-box  2 (SOX2),  nanog homeobox 
(NANOG), and Kruppel-like  factor 4  (KLF4)).  ALDH1A3 
interacts  with  ALDH1A1  through  alcohol  dehydrogenases 
(ADH4  and ADH1A).  This  result  is  in  accordance  to 
the   fact that  these  four  proteins  belong  to  group  of 
proteins  which  functions in  intracellular detoxification 
mechanisms. However, the  interaction  between ALDH1A3 
and   aforementioned   pluripotency   markers   remains 
unclear.
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Figure 2. ALDH1A3 gene expression in ASCs and UCSCs relative to those in CSCs. ASC and UCSC samples underwent RNA 
isolation. RT-PCR was then conducted and the Cq results were normalized by those in CSCs. A: ASCs (mean: 4.23) and UCSCs (mean: 
4.83) expressed similar level of ALDH1A3. No significant difference was found between both cells (p>0.05).  B: Electrophoresis result with 
100 bp DNA ladder shows that cDNA with a length of 104 bp was synthesized and amplified using PCR. This also confirms ALDH1A3 
as PCR product.
Discussion
ALDH1A1 and ALDH1A3, the isozymes of ALDH1 family, 
have been known to be the marker of stem cells and cancer 
stem cells. These enzymes are crucial to detoxify both 
endogenous and exogenous aldehyde substrates through 
NAD(P)+-dependent oxidation, emphasizing its capability 
in self-renewal, differentiation, and self-protection.(3,4) 
Nevertheless,  little  is  understood  on  the  specific  role 
of these genes in the pluripotency of MSCs from various 
sources.
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Figure 1. ALDH1A1 gene expression in ASCs and UCSCs. The results of qRT-PCR, represented as Cq, were normalized by those in 
ALDH+ breast CSCs. A: Relative expression of ALDH1A1 was significantly higher in ASCs (mean:1.4x10-3) than in UCSCs (mean: 8.1x10-
4) with p<0.01. B: Electrophoresis result with 100 bp DNA ladder shows that cDNA with a length of 117 bp was synthesized and amplified 
using PCR, confirming ALDH1A1 as PCR product. *=significance p<0.01 (tested by independent T-Test).
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Figure 3. Oct-4 gene expression in ASCs and UCSCs relative to those in CSCs. The mRNA of ASCs and UCSCs were isolated to 
undergo RT-PCR. The Cq gained were then normalized by those in CSCs. A: Relative expression of Oct-4 was expressed similarly between 
ASCs (mean: 0.39) and UCSCs (mean: 0.35). No significant difference was found between both cells (p>0.05). B: Electrophoresis result 
with 100 bp DNA ladder shows that cDNA with a length of 234 bp was synthesized and amplified using PCR. This also confirms Oct-4 as 
PCR product.
 The present study measures mRNA levels of 
ALDH1A1 and ALDH1A3 to investigate the synthesis 
of these genes. We observed higher expression level of 
ALDH1A1 in ASCs compared to UCSCs. This finding 
supports the previous study performed by Kiefer FW, et al., 
which stated that ALDH1A1 expression can be dominantly 
found in adipose tissue, especially White Adipose Tissue 
(WAT).(18) Greater ALDH1A1 expression in ASCs suggests 
that ALDH1A1 might contribute to certain properties 
which differ ASCs from UCSCs such as proliferation and 
adipogenic differentiation capability.(19,20) In contrast to 
ALDH1A1, ALDH1A3 was expressed in ASCs and UCSCs 
at similar levels. Albeit previous studies have reported that 
both ALDH1A1 and ALDH1A3 are expressed in MSCs 
(2,3), our results, for the first time, showed that ALDH1A1 
expression is related to different sources of MSCs while 
ALDH1A3 expression is not.
  Interestingly, ALDH1A1 expression in both ASCs and 
UCSCs is much lower than in human ALDH+ breast CSCs. 
Different expressions in MSCs and CSCs might be due to 
lower pluripotency of MSCs compared to CSCs which is 
caused by uncontrolled proliferation capability acquired 
by CSCs after repeated gene mutations. Nevertheless, 
ALDH1A1 contributes in a similar way to the pluripotent of 
both MSCs and CSCs, through Wnt pathway.(21-23)
 Similarly, Oct-4 mRNA was expressed greater in 
CSCs than MSCs. This finding emphasized similar trend 
of ALDH1A1 and Oct-4 gene expressions, which is best 
expressed by positive correlation between both genes. 
Hence, since this research studied the regulation of mRNA 
synthesis of each gene, this parallel findings between 
ALDH1A1 and Oct-4 mRNA expression propose the 
possibility these genes could be expressed due to similar 
regulatory factors as the stimulation. 
 In contrast to ALDH1A1 and Oct-4, our study 
emphasizes that ALDH1A3 is found in a higher level in 
MSCs than in CSCs. This suggests that ALDH1A3 plays a 
more significant role in MSCs than in CSCs and has little or 
no contribution to the pluripotency of stem cells and CSCs. 
Purnamawati, et al., found that the expression of ALDH1A3 
is consistent with TGF-b1 which plays a role in inhibiting 
cell proliferation, cell motility, invasion, and metastasis.(24) 
This finding is also supported by previous study by Crocker, 
et al., which stated that unlike ALDH1A1, ALDH1A3 is 
found to have no effect on the proliferation of human 
breast CSCs.(25) Our result obtained from in silico analysis 
confirms that in contrast to ALDH1A1, ALDH1A3 was found 
not to interact directly to the pluripotency markers, Oct-4, 
SOX2, NANOG, and KLF4. Further studies are required to 
elaborate the specific role of ALDH1A3 in MSCs.
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Figure 4. Analysis of ALDH interaction with pluripotency genes from STRING database. In silico study was conducted using 
String 9.1 Software to analyze the protein-protein interactions between ALDH1 and other pluripotency markers. Interactions between 
each protein was analyzed from several categories including from known interactions (curated databases and experimentally determined), 
predicted interactions (gene neighborhood, gene fusions, and gene co-occurrence), and others such as textmining, co-expression and 
protein homology.
  From these findings, it can be inferred that ASCs and 
UCSCs express different levels of ALDH1A1 and ALDH1A3. 
This implies on the application of MSCs, such as in the use 
of ASCs in fat grafting of breast reconstruction after breast 
cancer surgery (26) and UCSCs in tissue engineering.(5,27) 
Different usage of stem cells in clinical settings might be due 
to various differentiation capacities that they possess. ASCs 
show excellent differentiation and clonal ability to adipose 
tissue.(28,29) Meanwhile, UCSCs present outstanding 
capability in differentiating to cardiomyocyte, fibrocartilage 
tissue, or even collagen, making it suitable to be used in 
tissue engineering.(9,12)
 Nevertheless, several reports have shown the 
possibility of cancer recurrence post-ASCs fat grafting.
(30,31) Mazur has reported the cancer recurrence in 3.7% 
patients treated with ASC-enriched fat. Although it is 
not differ significantly to the control group (4.13%), the 
recurrence might be caused by the pro-angiogenesis and 
adipogenesis capabilities from ASCs, which support the 
survival of neighboring malignant cells.(32,33) Knowing 
these facts, it is prudent to consider other type of MSCs to 
be used in fat grafting of breast reconstruction after breast 
cancer surgery. However, little studies have been performed 
to study the benefits of UCSCs in fat grafting. This condition 
might be due to the difficulty in provision of appropriate 
MSCs number, which is not usually adequate to be used in 
major clinical disorders.(34)
 This study measures the mRNA expression to 
investigate the synthesis of the respective genes. Thus, to 
further ensure the pluripotency and specific roles of each 
gene in stem cells, it is recommended to conduct further 
research to investigate more on the role of the proteins of 
these genes in ASCs and UCSCs.
Conclusion
Taken together, we conclude that ALDH1A1 and ALDH1A3 
were distinctly expressed in UCSCs and ASCs which might 
be associated with unique properties of the aforementioned 
stem cells. The distinct properties of ASCs and UCSCs are 
important to be taken into account in the application of both 
of the MSCs, particularly in stem cell therapy.
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